Bryant Dunetz

Enrichment of PI3K-AKT–mTOR Pathway Activation in Hepatic Metastases from Breast Cancer

Mariaelena Pierobon, Corinne Ramos, Shukmei Wong et al. · Clinical Cancer Research · 2017 · 96 citations

Medicine, Cancer Biology, Oncology +17

A pilot study utilizing multi-omic molecular profiling to find potential targets and select individualized treatments for patients with previously treated metastatic breast cancer

Gayle Jameson, Emanuel F. Petricoin, Jasgit C. Sachdev et al. · Breast Cancer Research and Treatment · 2014 · 82 citations

Medicine, Molecular Medicine, Oncology +17

AKT/mTOR signaling modulates resistance to endocrine therapy and CDK4/6 inhibition in metastatic breast cancers

Maysa Abu‐Khalaf, K. Alex Hodge, Christos Hatzis et al. · npj Precision Oncology · 2023 · 36 citations · Full text

Medicine, Oncology, Pharmacology +17

PD-L1 quantification across tumor types using the reverse phase protein microarray: implications for precision medicine

Elisa Baldelli, K. Alex Hodge, Guido Bellezza et al. · Journal for ImmunoTherapy of Cancer · 2021 · 15 citations · Full text

Life Sciences, Immunology, Oncology +17

Multi‐omic molecular profiling guide’s efficacious treatment selection in refractory metastatic breast cancer: a prospective phase II clinical trial

Mariaelena Pierobon, Nicholas J. Robert, Donald W. Northfelt et al. · Molecular Oncology · 2021 · 14 citations · Full text

Medicine, Molecular Medicine, Oncology +17